Company intelligence / Profile preview
GenAhead Bio
Fujisawa, Kanagawa, Japan
- Ownership
- Private
- Development stage
- Other
01
Overview
GenAhead Bio provides high-efficiency CRISPR/Cas9 genome editing services based on its proprietary SNIPER method and is conducting preclinical research on nucleic acid therapeutics (antisense oligonucleotides and siRNA) delivered via Antibody-Nucleic acid Conjugates, including siRNA delivery to skeletal muscle via anti-transferrin receptor (CD71) antibodies with therapeutic effects in muscular disease models.[1][3][5]
- Therapeutic areas
- NeurologyRare Diseases
- Modalities
- CRISPR-based therapyAntisense oligonucleotideSmall interfering RNARNA therapyAntibodyAntibody-drug conjugateNanoparticle
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
ERS Genomics (CRISPR/Cas9 license)[3][5]Broad Institute (CRISPR/Cas license)[3]ReproCELL (iPSC and cell product distribution partnership)[5]Takeda Pharmaceutical (spin-out origin and technology transfer)[3][5]
Beyond the preview
Go deeper on GenAhead Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GenAhead Bio.